#HOT/USDT#HOT
The price is moving in a descending channel on the 4-hour frame upwards and is expected to continue
We have a trend to stabilize above the moving average 100 again
We have a downtrend on the RSI indicator that supports the rise by breaking it upwards
We have a support area at the lower limit of the channel at a price of 0.001500
Entry price 0.001712
First target 0.001830
Second target 0.001919
Third target 0.002034
Hotstocks
Stitch Fix, IncOn the above weekly chart price action has corrected 97% since the sell signal printed in February 2021. A number of reasons now exist to have a long position, including:
1) You know why..
2) Price action and RSI resistance breakouts.
3) Price action prints a double with higher lows in RSI.
4) Stochastic RSI prints hidden bullish divergence, fantastic.
5) No stock splits.
Is it possible price action falls further? Sure.
Is it probable? No.
Ww
Type: investment
Risk: <=6% of portfolio
Timeframe: Don’t know.
Return: Will say somewhere else
Stop loss: <= 2.40
Daily Candles on AMCDon't shoot the messenger. I am not a professional.
I think you are going to see a breakdown of AMC to about $6.15. The last three candles on the chart is a bearish formation, it recently broke its trendline and there is no buying volume. It is at a heavy resistance at around $9.70.
There is also the subject of parity with APE. Where the 2 prices meet in the middle and trade together. APE is very low right now and if there is a parity it would most likely be in the $6.50 range.
All opinions are welcome!
CYXTALL TIME HIGHS>> Looking to take a long on this one. Will look for possible continuation upside. Either want to see a week or two of consolidation. Or take a smaller entry with a stop at the low of day on the day i enter. Selling halfs on pushed then trailing with 21ema(faint red line)
Humanigen Is Set to Save the World However, Bears Want HavocThe waves never lie, though sometimes we read them wrong.
Humanigen has an enormous future ahead of itself.
Follow me and say hello for more insight :)
HEROMOTOCO Haven't seen a cleaner Diamond breakout in quite some time.
Although diamond top upward breakouts have poor performance statistics, the Cleanness of this pattern + Above average Volumes on breakout + MACD bullish crossover is persuading me to take action.
Target 3130
Keep SL according to your risk appetite.
*********************************************************************************************
DISCLAIMER: I am not a SEBI registered investment advisor.
This content is for educational purposes only.
Invest capital at your own risk only after doing your own due diligence
*********************************************************************************************
23.30% SHORT INTEREST. SILVER SHORTAGE. SHORT SQUEEZEThe United States Mint just announced a shortage of Gold & Silver. See links below.
www.theepochtimes.com
www.reuters.com
Silver has been artificially & fraudulently held down for decades while gold continued to rise.
JP Morgan just bought "FAKE" Silver by creating ("Procured") 61,250 contracts, or 61,350,000 new ounces of Silver (1,000 oz bars) in a matter of days. JP Morgan has been creating Silver out of thin air with nothing to back it up.
When the house of cards falls, you will want physical Silver not contracts, worthless pieces of paper.
First Majestic cannot mine Silver fast enough, everything they have is sold out. Check their website. (Earrings should be a gigantic beat)
store.firstmajestic.com - (Website Bullion Store Message - Due to the influx of silver orders we have to temporarily suspend sales for maintenance we will try our best to get back online as soon as possible.)
Folks, there is a shortage of Silver and the big banks are artificially holding the Silver price down. They cannot keep holding the Silver price down especially with robust demand now.
If you look at inflation, silver should be trading around $1000.00.
Gold & Silver have been manipulated for decades. The manipulation needs to stop!
Today silver is invaluable to solder and brazing alloys, batteries, dentistry, glass coatings, LED chips, medicine, nuclear reactors, photography, photovoltaic (or solar) energy, RFID chips (for tracking parcels or shipments worldwide), semiconductors, touch screens, water purification, wood preservatives and many other industrial uses. Washington-based industry group the Silver Institute calls it "the indispensable metal".
The biggest consumers of silver for industrial applications this past decade have been the US, Canada, China, India, Japan, South Korea, Germany and Russia. Over that time silver demand from older industries has faded, only to be replaced by new technological uses.
With a silver shortage brewing, and First Majestic Silver reporting earnings on or about February 18, 2021, the stock looks ripe for another short squeeze!
I moved into Gold & Silver Bullion - I am out of the stock market.
If you like short squeezes, this silver stock looks ripe for the picking!
The last squeeze spiked the stock to $24.01 within days.
I think it will happen again very soon!
Best of Luck!
Unheard gross margins of 95% and a $800B TAM : $GDRXGoodRx is a free-to-use service that allows Americans to find the lowest-cost prescription drugs in their area. The company makes money by receiving a commission for every prescription order filled via its coupons, which are accepted by nearly all 70,000 pharmacies across the country.
-Most Downloaded medical app in US with 4.8/5 rating(700,000+ reviews)
-Partnership with Kroger
-Competing with TDOC with the launch of HeyDoctor
- Rising prices of pharmaceuticals and their mission is to lower the cost of healthcare
-95% Gross margin (What?!?!). 30% Operating margin.
- $75M Free cash flow.
- TAM $800 Mn
- NPS 86
- 4.6/5 Glassdoor
- Founder led
Concerns,
1. P/S of 37.1 and 201 PE. Average PE in healthcare is 24.
2. IPO hype(good for trades though)
3. 94% of top line revenue still coming in from prescription stream(concentration risk?) which grew 42% Q1.
4. Regulations
5. International expansion?
6. 4 holders own 60-65% of the company(Both good and bad)
TA,
1. Wedge breakout
2. Potential base of Cup.
3. Low volume on Pullback
Not a long term position yet. Swing trade.
Entry : break of 52
Stop loss : 49 (-7.8%)
Investing in LIDAR (Driverless Vehicle Technology)Driverless vehicles are becoming a reality today because of a dramatic confluence of many technologies: computing power, cameras, sensors, laser range finders (called LIDAR), GPS, and artificial intelligence software, just to name a few.
But my team and I believe there are two companies responsible for by far the most “critical components” for the best self-driving cars.
The first company makes the most technologically advanced “brain” and “nervous system” for autonomous vehicles. This firm has already partnered with many of the leading companies in this space, including BMW, Hyundai, Audi, Intel, and Lyft, just to name a few.
This technology helped complete the longest automated drive ever… from San Francisco to New York City… and was selected by one national government to be the technology behind a country’s autonomous taxi’s set to hit the road in 2022.
This stock is still a great bargain today—and I strongly recommend you take a stake—I think you could make many times your money in the next few years.
The other key technology you want to own in the driverless technology space is the company that provides the computing power for many of today’s driverless vehicles.
$4672.50 in 2006 to $6.00 - Huge Demand, Robust EarningsPacific Ethanol, Inc. produces and markets low-carbon renewable fuels and alcohol products in the United States. The company operates in two segments, Production and Marketing. It produces and markets ethanol; and co-products, such as wet and dry distillers grains, wet and dry corn gluten feed, condensed distillers solubles, corn gluten meal, corn germ, corn oil, dried yeast, and CO2, as well as markets ethanol produced by third parties. The company also offers ethanol transportation, storage, and delivery services through third-party service providers. It sells ethanol to integrated oil companies and gasoline marketers; distillers grains and other feed co-products to dairies and feedlots; and corn oil to poultry and biodiesel customers. The company owns and operates nine ethanol production facilities, including four plants located in the Western states of California, Oregon, and Idaho; and five plants in the Midwestern states of Illinois and Nebraska. Pacific Ethanol, Inc. was founded in 2003 and is headquartered in Sacramento, California.
I think this is the beginning of something huge. As I noted, the stock hit a high of $4672.50 in 2006.
Demand for Alcohol products in the United States and around the World is outstripping supply as can be seen in Pacific Ethanol's last earnings report below.
The company continues to pay down its debt too.
August 11, 2020
Shares of Pacific Ethanol (NASDAQ:PEIX) moved higher by 38.29% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 258.82% over the past year to $0.27, which beat the estimate of ($0.20). Revenue of $212,074,000 beat the estimate of $174,200,000.
This is a pure turnaround play in my opinion with a lot of room to run a lot higher.
Daily Chart is Bullish with most indicators trending up, Bullish
The stock continues to make new 52-week highs.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
BioNTech Stock Will Soar With Its First-Mover Vaccine AdvantageNASDAQ:BNTX a German company and its american partner NYSE:PFE
will likely have a first-mover advantage in the coronavirus vaccine race in the U.S. This will affect both stocks, once the final vaccine results are in.
Assuming the bottom is in and we are about to continue the Trend as previously, im expecting a big move after the approval, so dont forget to take risk of the table!
The reason for this is that the two companies are expecting to be the first to produce large-scale results from their Phase 2/3 clinical trials in October, according to Barron’s.
Depending on how effective their vaccine is, the U.S. Food and Drug Administration may even grant it emergency-use authorization
The advantage of their trial is that it is large, involving more than 30,000 participants.
The FDA wants to see at least 50% efficacy in trials before granting any Covid-19 authorization.
Why BioNTechs Vaccine Looks Like a Winner
With Pfizer in the back FDA and President Donald Trump are likely to move quickly.
According to them even the first small study with 24 Persons that took their messenger RNA vaccine produced antibodies.
With a lower doses usage of the vaccine and developed antibodies after 28 days — at levels about two times higher than in normal, recovering Covid-19 patients.
BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech’s BNT162 to Hong Kong SAR and Macao SAR
Also a Deal to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidat
This combined with the huge buying volume and market shifts will grant momentum for bigger goals.
Just think about what ccould happen when they get kinda a monopol situation going for them.
Thank you for take the time and reading this and as always stay storng in those shaky times!
Sebastian
Bullish Charts - Online Sports Betting Play & New Boyd ContractInternational Game Technology PLC operates and provides gaming technology products and services worldwide. The company operates through four segments: North America Gaming and Interactive, North America Lottery, International, and Italy. It designs, sells, and operates a suite of point-of-sale machines that reconciles lottery funds between the retailer and lottery authority; provides online lottery transaction processing systems; produces instant ticket games; and offers printing services, such as instant ticket marketing plans and graphic design, programming, packaging, shipping, and delivery services. The company also designs, develops, assembles, and provides cabinets, games, systems, and software for gamin market, as well as offers gaming management systems for casino management, customer relationship management, patron management, and server-based gaming. In addition, it provides video lottery terminals (VLT), VLT central systems, and VLT games; and amusement with prize machines and games to licensed operators. Further, the company offers sports betting services on sports and motor sports events, and non-sporting events, as well as sports betting technology and management services. Additionally, it provides digital gaming products and services, including poker, bingo, and online casino table and slot games; social casino content; and remote game server, as well as iGaming systems and digital platforms that offers player account management, advanced marketing and analytical, and payment system services. The company processes commercial transactions, such as prepaid cellular telephone recharges, bill payments, e-vouchers and retail-based programs, electronic tax payments, prepaid card recharges, and stamp duty and money transfers services. The company was formerly known as GTECH S.p.A. and changed its name to International Game Technology PLC in April 2015. The company was founded in 2014 and is headquartered in London, the United Kingdom. International Game Technology PLC operates as a subsidiary of De Agostini S.p.A.
IGT is known in the industry and is well respected.
The company started jumping into online sports betting. This is a hidden gem teaming up with some huge players / casinos. See news below.
IGT Announces Sports Betting Technology Agreement with Boyd Gaming
finance.yahoo.com
IGT, FanDuel Ink Multi-Year Sports Betting Deal, Shares Rise 7%
finance.yahoo.com
Target: $18 to $20 or higher
Weekly Chart looks like a Bull Flag
Daily Chart: Volume, PMO, MACD, RSI, OBV, Stochastic and Accumulation are trending up, Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Extreamly Undervalued - $10 Billion Stock Repurchase ProgramIntel Corporation provides computing, networking, data storage, and communication solutions worldwide. It operates through Data Center Group, Internet of Things Group, Non-Volatile Memory Solutions Group, Programmable Solutions Group, Client Computing Group, and All Other segments. The company offers platform products, such as CPU and chipset, system-on-chip, and multichip package products for cloud, enterprise, and communication infrastructure markets. It also provides NAND flash memory and DC persistent products for enterprise and cloud-based data centers, and users of business and consumer desktops and laptops; programmable semiconductors, such as field-programmable gate arrays, application-specific integrated circuits, and related products for communications, data center, industrial, and military markets; and various processors for notebooks, mobiles, and desktop PCs. In addition, it offers boards and systems, such as server boards and small form factor systems; and connectivity products for cellular modems, Ethernet controllers, silicon photonics, Wi-Fi, and Bluetooth. Further, the company develops computer vision and machine learning- based sensing, data analysis, localization, mapping, and driving policy technologies for advanced driver assistance systems and autonomous driving. It serves original equipment manufacturers, original design manufacturers, industrial and communication equipment manufacturers, and cloud service providers. The company was founded in 1968 and is headquartered in Santa Clara, California.
Great opportunity to buy the "KING" of the industry!
Intel announced a $10 Billion stock repurchase program.
The stock is undervalued at current levels especially compared to overpriced AMD.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Online Learning in ChinaRYB Education, Inc. provides early childhood education service in the People's Republic of China. The company offers kindergarten services to 2-6-year-old children; and play-and-learn centers services for the joint participation of 0-6-year-old children and their adult family members to promote children's development, foster bonding with family, and prepare them for their entry into kindergartens and primary schools. It also develops and sells educational products and services, such as teaching aids, educational toys, at-home educational products, and school uniforms through franchisees and other business partners, as well as directly to a market of families. As of December 31, 2019, it operated 100 directly operated and 250 franchise kindergartens; and 6 play-and-learn centers. The company was formerly known as Top Margin Limited and changed its name to RYB Education, Inc. in June 2017. RYB Education, Inc. was founded in 1998 and is based in Beijing, China.
Daily Chart is Bullish
Broke out above the cloud yesterday.
Indicators are Bullish
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Disposable Surgical Robotic Device - BIG News Coming 8/17/20Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System
Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference
HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System.
finance.yahoo.com
On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00.
I think this device could be a game changer.
Disposable medical devices is where the future is going especially for sanitary reasons.
Watch this stock Monday, 8/17/2020, it could run hard.
I think the stock has been consolidating for a while and is coiling and ready to explode higher.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Bitcoin Record Highs. Gold Record Highs. Launched in 2013, the BIT is sponsored by Alternative Currency Asset Management (ACAM), a wholly-owned subsidiary of SecondMarket Holdings, Inc. and an affiliate of SecondMarket, Inc. (custodian, marketing and distribution partner). ACAM has engaged leading service providers Ernst & Young (auditor).
Chart looks like this one is going to $17 to $20 real soon.
Daily Chart
PMO is spiking up, Bullish
Volume is Bullish
RSI is Bullish
MACD is Bullish
Accumulation is Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Beat Earnings. Raised Guidance. No Debt. USA Protective GearAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
Net Sales of $25.5 Million, an Increase of 123.4% Year-over-Year
Provides Update on Orders for Personal Protective Equipment (PPE)
Net sales for the second quarter of 2020 were $25.5 million, compared to $11.4 million for the second quarter of 2019, up 123.4% year-over-year.
Net income for the second quarter of 2020 was $6.2 million, or $0.46 per diluted share, compared to $1.0 million, or $0.08 per diluted share, for the second quarter of 2019, up 475% on a per share basis.
NOGALES, Ariz., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three month period ended June 30, 2020.
finance.yahoo.com
Need I say anymore? Earnings blew past Wall Street Estimates. APT raised guidance and the company has no debt.
Protective gear and N95 masks will be a part of the Worldwide dress code through 2020 and into 2021 even if a vaccine is approved because not everyone will want to take the vaccine shot.
Today's sell off was outrageous and an early Christmas gift for anyone looking for a quality company that makes protective gear & N95 masks in the USA!
Target: $32
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Huge Earrings BeatDURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for pharmaceutical and medical device clients for use as raw materials in their products under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase I and II development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's oral and injectable delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Zogenix, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.
This morning Durect reported earrings that blew away Wall Street Estimates.
Q2 EPS $0.07 Up From $(0.04) YoY, Sales $25 Million Beat $11.48 Million Estimate
Sales more than doubled estimates.
Daily Chart is Bullish
Indicators are rising, Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Rapid Recovery Respiratory Failure - COVID-19 TreatmentRelief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary hypertension; and atexakin alfa that has completed Phase I clinical trial to treat peripheral diabetic neuropathy. Relief Therapeutics Holding AG is based in Geneva, Switzerland.
RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells
- Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) was seen in patients with severe medical comorbidities after three days of treatment with RLF-100 under FDA Emergency Use IND authorization at multiple clinical sites
- Aviptadil is being developed as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes
- RLF-100 is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide VIP), which has been granted FDA Fast Track Designation, FDA emergency use IND authorization, and an expanded access protocol
finance.yahoo.com
I think this stock could spike like Moderna
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.